As of December 2024 Spyre Therapeutics has a market cap of A$2.23 Billion. This makes Spyre Therapeutics the world's 4931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 22nd, 2024 the market cap of Spyre Therapeutics was reported to be: